Literature DB >> 19652540

The Myc-nucleophosmin-ARF network: a complex web unveiled.

Zhaoliang Li1, Stephen R Hann.   

Abstract

The multifunctional nucleolar proteins, nucleophosmin (NPM) and the tumor suppressor ARF, have been assigned numerous roles in diverse cellular processes impacting cellular proliferation, tumorigenesis and apoptosis. In addition, both proteins have been linked to the oncogenic function of c-Myc, a transcription factor that drives the majority of human cancers. Both proteins are induced by oncogenic c-Myc, but have opposing outcomes. Whereas loss of ARF accelerates c-Myc-induced tumorigenesis, NPM overexpression enhances c-Myc transformation. Accordingly, ARF expression is lost in many tumors, while NPM expression is elevated. Previously, we demonstrated that ARF interacts directly with c-Myc, leading to inhibition of its transforming activity while enhancing its apoptotic activity, independently of p53. We have recently shown that NPM also binds directly to c-Myc, but with opposite effects compared to ARF. NPM dramatically enhances the oncogenic activity of c-Myc, independently of ARF and p53. In tumor cells, the ARF-p53 pathway is often inactivated while NPM is elevated. However, when NPM and ARF are both expressed with oncogenic c-Myc the outcome of the interactions becomes more complex, since NPM and ARF also interact directly and NPM controls ARF localization. In this report we demonstrate that in the presence of ARF, NPM overexpression dramatically inhibits c-Myc-induced p53-independent apoptosis, while enhancing proliferation and transformation. We find that NPM sequesters ARF in nucleoli, blocking the relocalization of ARF to the nucleoplasm caused by activation of c-Myc. Therefore, the fate of a cell to undergo apoptosis or become transformed is dependent on this complex interacting network of oncogenic and tumor suppressor proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652540      PMCID: PMC3234343          DOI: 10.4161/cc.8.17.9418

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

3.  Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.

Authors:  A W Lin; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  The myc oncogene: MarvelouslY Complex.

Authors:  Sara K Oster; Cynthia S W Ho; Erinn L Soucie; Linda Z Penn
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

5.  Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.

Authors:  Masataka Sugimoto; Mei-Ling Kuo; Martine F Roussel; Charles J Sherr
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

6.  ARF function does not require p53 stabilization or Mdm2 relocalization.

Authors:  Chandrashekhar Korgaonkar; Lili Zhao; Modestos Modestou; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.

Authors:  S Llanos; P A Clark; J Rowe; G Peters
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

8.  Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.

Authors:  Abhishek Datta; Alo Nag; Wei Pan; Nissim Hay; Andrei L Gartel; Oscar Colamonici; Yasuji Mori; Pradip Raychaudhuri
Journal:  J Biol Chem       Date:  2004-06-15       Impact factor: 5.157

9.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Nucleophosmin regulates the stability and transcriptional activity of p53.

Authors:  Emanuela Colombo; Jean-Christophe Marine; Davide Danovi; Brunangelo Falini; Pier Giuseppe Pelicci
Journal:  Nat Cell Biol       Date:  2002-07       Impact factor: 28.824

View more
  26 in total

1.  Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.

Authors:  Z Li; S R Hann
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

Review 2.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

3.  Aberrant Expression of p14ARF in Human Cancers: A New Biomarker?

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Tumor Microenviron       Date:  2019-02-04

Review 4.  Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.

Authors:  Jo Ishizawa; Kensuke Kojima; Numsen Hail; Yoko Tabe; Michael Andreeff
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

Review 5.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

6.  Structural polymorphism in the N-terminal oligomerization domain of NPM1.

Authors:  Diana M Mitrea; Christy R Grace; Marija Buljan; Mi-Kyung Yun; Nicholas J Pytel; John Satumba; Amanda Nourse; Cheon-Gil Park; M Madan Babu; Stephen W White; Richard W Kriwacki
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

7.  tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.

Authors:  Kristin E N Watt; Cynthia L Neben; Shawn Hall; Amy E Merrill; Paul A Trainor
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 8.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

9.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

Review 10.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.